title: Protein hydrolysate/leucine co-ingestion reduces the prevalence of hyperglycemia in type 2 diabetic patients.
authors.affiliation: Department of Human Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, Netherlands. r.manders@hb.unimaas.nl
authors.forename: Ralph J F
authors.initials: RJ
authors.lastname: Manders
authors.forename: Stephan F E
authors.initials: SF
authors.lastname: Praet
authors.forename: Ruth C R
authors.initials: RC
authors.lastname: Meex
authors.forename: René
authors.initials: R
authors.lastname: Koopman
authors.forename: André L
authors.initials: AL
authors.lastname: de Roos
authors.forename: Anton J M
authors.initials: AJ
authors.lastname: Wagenmakers
authors.forename: Wim H M
authors.initials: WH
authors.lastname: Saris
authors.forename: Luc J C
authors.initials: LJ
authors.lastname: van Loon
mesh_terms: D000284:Administration, Oral; D000328:Adult; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D002940:Circadian Rhythm; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D006801:Humans; D006943:Hyperglycemia / Q000453:epidemiology* / Q000517:prevention & control*; D007930:Leucine / Q000008:administration & dosage / Q000627:therapeutic use*; D015995:Prevalence; D011492:Protein Hydrolysates / Q000008:administration & dosage / Q000627:therapeutic use*; D012016:Reference Values
chemical_list: D001786:Blood Glucose; D011492:Protein Hydrolysates; D007930:Leucine